Pricing Log in Create free account

ProQR Therapeutics N.V. (PRQR) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

ProQR Therapeutics N.V. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. ProQR Therapeutics N.V. and Zentalis Pharmaceuticals, Inc. are of similar size ($212.1M and $204.6M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −228.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Zentalis Pharmaceuticals, Inc. leads on 8 and ProQR Therapeutics N.V. on 5.

Valuation

Metric PRQR ZNTL Biotechnology median
P/E n/m n/m 8.50
P/S 6.71 n/m 9.71
P/B 1.56 1.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.15 0.64
EV/Sales 0.85 n/m 9.21
Earnings yield (35.11%) (91.55%) (33.15%)
Free cash flow yield (39.84%) (84.25%) (25.50%)

Profitability

Metric PRQR ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (233.33%) 0.00% 0.00%
Net margin (228.71%) 0.00% 0.00%
Free cash flow margin (267.36%) 0.00% 0.00%
Return on equity (58.29%) (66.75%) (56.36%)
Return on assets (31.53%) (49.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PRQR ZNTL Biotechnology median
Revenue growth (TTM) 19.72% — 6.02%
EPS growth (last fiscal year) (28.57%) 18.03% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRQR ZNTL Biotechnology median
Debt to equity 0.06 0.00 0.00
Current ratio 3.49 4.82 4.72
Net debt to EBITDA 2.15 1.59 0.96

Dividend

Metric PRQR ZNTL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PRQR ZNTL Biotechnology median
Market cap 204.63m 212.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack